{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T14:18:35Z","timestamp":1774361915706,"version":"3.50.1"},"reference-count":37,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2010,10,6]],"date-time":"2010-10-06T00:00:00Z","timestamp":1286323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2010,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>In suspected nonmetastatic adrenocortical carcinoma (ACC) a careful preoperative diagnostic work up is needed including comprehensive endocrine analysis as recommended by the European Network for the Study of Adrenal Tumors (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.ENSAT.org\/ACC.htm\">http:\/\/www.ENSAT.org\/ACC.htm<\/jats:ext-link>). Staging prior surgery, in particular chest CT, is indispensable to exclude distant metastases. Open surgery is still the recommended approach in ACC. However, in localized non\u2010invasive ACC with a diameter &lt;10\u2003cm laparoscopic adrenalectomy by an expert surgeon is probably similarly effective and safe. As many patients will suffer from tumor recurrence after seemingly complete removal of ACC, adjuvant treatment based on the individual risk status is recommended. Key factors for risk assessment are tumor stage, resection status and the proliferation marker Ki67. All patients considered at high risk for recurrence should receive adjuvant mitotane for a minimum of 2\u2003years aiming at a drug level of 14\u201320\u2003mg\/l. In selected patients (e.g. <jats:italic>R<\/jats:italic>1 resection) we recommend additional radiotherapy of the tumor bed. Patients with a low\/intermediate risk for recurrence should be included in the Adiuvo trial comparing adjuvant mitotane with observation only (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.adiuvo-trial.org\">http:\/\/www.adiuvo\u2010trial.org<\/jats:ext-link>). In low\/intermediate risk patients who cannot be included in this trial observation only can be justified in cases with a tumor diameter of &lt;8\u2003cm and no microscopic evidence for invasion of blood vessels or tumor capsule. In all patients a structured follow\u2010up for 10\u2003years is strongly recommended.<\/jats:p>","DOI":"10.1111\/j.1365-2265.2010.03867.x","type":"journal-article","created":{"date-parts":[[2010,8,29]],"date-time":"2010-08-29T22:48:31Z","timestamp":1283122111000},"page":"561-565","source":"Crossref","is-referenced-by-count":33,"title":["What is the best approach to an apparently nonmetastatic adrenocortical carcinoma?"],"prefix":"10.1111","volume":"73","author":[{"given":"Martin","family":"Fassnacht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Allolio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,10,6]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa063360"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1677\/erc.1.01130"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2008.10.008"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03351068"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2002-0031"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2639"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.171.1.9648789"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2342031876"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-07-0045"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2433051978"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0720-048X(01)00443-0"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2302"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12149-009-0246-4"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2612"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1540"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24030"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1677\/erc.1.01029"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2006.07.010"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-010-0532-2"},{"key":"e_1_2_9_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.01.036"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.06.024"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2005.09.012"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-09-1096"},{"key":"e_1_2_9_25_2","first-page":"963","article-title":"An eleven\u2010year experience with adrenocortical carcinoma","volume":"112","author":"Pommier R.F.","year":"1992","journal-title":"Surgery"},{"key":"e_1_2_9_26_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.4.941"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008377915129"},{"key":"e_1_2_9_28_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1007"},{"key":"e_1_2_9_29_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0803"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.5958"},{"key":"e_1_2_9_31_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0579"},{"key":"e_1_2_9_32_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.5678"},{"key":"e_1_2_9_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24331"},{"key":"e_1_2_9_34_2","article-title":"Adjuvant and Definitive Radiotherapy for Adrenocortical Carcinoma","author":"Sabolch A.","year":"2010","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"e_1_2_9_35_2","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-08-0103"},{"key":"e_1_2_9_36_2","first-page":"386","article-title":"Mitotane for adrenocortical carcinoma treatment","volume":"6","author":"Hahner S.","year":"2005","journal-title":"Current Opinion in Investigational Drugs"},{"key":"e_1_2_9_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1994.183"},{"key":"e_1_2_9_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010915)92:6<1385::AID-CNCR1461>3.0.CO;2-2"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2010.03867.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.2010.03867.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T12:56:30Z","timestamp":1698756990000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2010.03867.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,6]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["10.1111\/j.1365-2265.2010.03867.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2010.03867.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,6]]}}}